Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines

The lack of validated immunological correlates of protection makes tuberculosis vaccine development difficult and expensive. Using intradermal bacille Calmette-Guréin (BCG) as a surrogate for aerosol Mycobacterium tuberculosis (M.tb) in a controlled human infection model could facilitate vaccine dev...

Podrobná bibliografie
Hlavní autoři:	Harris, S, White, A, Stockdale, L, Tanner, R, Sibley, L, Sarfas, C, Meyer, J, Peter, J, O'Shea, M, Manjaly Thomas, Z, Hamidi, A, Satti, I, Dennis, M, McShane, H, Sharpe, S
Médium:	Journal article
Vydáno:	Elsevier 2017

Podobné jednotky

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
Autor: Tanner, R, a další
Vydáno: (2021)

Optimisation of a human BCG challenge model
Autor: Wilkie, M, a další
Vydáno: (2015)

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
Autor: Peralta-Álvarez, MP, a další
Vydáno: (2024)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
Autor: Harris, S, a další
Vydáno: (2013)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
Autor: Harris, SA, a další
Vydáno: (2014)

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
Autor: Marco Polo Peralta-Álvarez, a další
Vydáno: (2024-11-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
Autor: Tanner, R, a další
Vydáno: (2021)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
Autor: Rachel Tanner, a další
Vydáno: (2021-01-01)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
Autor: Alvarez, MPP, a další
Vydáno: (2024)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Autor: Minhinnick, A, a další
Vydáno: (2016)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
Autor: Marco Polo Peralta Alvarez, a další
Vydáno: (2024-05-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 1; peer review: 2 approved]
Autor: Rachel Tanner, a další
Vydáno: (2021-03-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
Autor: Rachel Tanner, a další
Vydáno: (2021-09-01)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
Autor: Matsumiya, M, a další
Vydáno: (2014)

Immune cell population dynamics following neonatal BCG vaccination and aerosol BCG revaccination in rhesus macaques
Autor: Laura Sibley, a další
Vydáno: (2024-07-01)

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
Autor: Sheehan, S, a další
Vydáno: (2015)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
Autor: Satti, I, a další
Vydáno: (2014)

Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates
Autor: Andrew D. White, a další
Vydáno: (2023-10-01)

Development of a primate model for tuberculosis vaccine research: IFN-gamma responses induced by BCG vaccination and M-tuberculosis infection in macaques
Autor: Dowall, S, a další
Vydáno: (2007)

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination
Autor: Bitencourt, J, a další
Vydáno: (2021)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against <i>M. tb</i> Challenge
Autor: Alexandra L. Morrison, a další
Vydáno: (2023-10-01)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
Autor: Fletcher, H, a další
Vydáno: (2016)

Predicting IFN-γ responses after BCG vaccination in humans from macaques: A proof-of-concept study of Immunostimulation/Immunodynamic modelling methods
Autor: Rhodes, S, a další
Vydáno: (2017)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
Autor: Harris, S, a další
Vydáno: (2011)

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.
Autor: Fletcher, H, a další
Vydáno: (2016)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
Autor: Fletcher, H, a další
Vydáno: (2013)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
Autor: Villarreal-Ramos, B, a další
Vydáno: (2017)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
Autor: Harris, SA, a další
Vydáno: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
Autor: Satti, I, a další
Vydáno: (2014)

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
Autor: Charlotte Sarfas, a další
Vydáno: (2021-10-01)

The humoral immune response to BCG vaccination
Autor: Tanner, R, a další
Vydáno: (2019)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
Autor: O'Shea, M, a další
Vydáno: (2018)

Revaccination with BCG: does it work?
Autor: McShane, H
Vydáno: (2024)

Understanding BCG is the key to improving it.
Autor: McShane, H
Vydáno: (2013)

Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination
Autor: Julia Bitencourt, a další
Vydáno: (2022-01-01)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
Autor: Helen A. Fletcher, a další
Vydáno: (2016-04-01)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Autor: Satti, I, a další
Vydáno: (2022)

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity
Autor: Minhinnick, A, a další
Vydáno: (2015)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
Autor: Minassian, A, a další
Vydáno: (2011)

TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination
Autor: Andrew D. White, a další
Vydáno: (2021-08-01)